Przewlekłe codzienne bóle głowy
Rokowania, prognozy i postęp choroby

Chroniczne codzienne bóle głowy (CDH) dotyczą 2-4% dorosłych, z ponad 30% pacjentów doświadczających codziennych objawów. Rokowanie jest złożone i zależy od czynników takich jak częstotliwość epizodów bólowych, nadużywanie leków przeciwbólowych, obecność bólu przewlekłego mięśniowo-szkieletowego oraz otyłość. U pacjentów z codziennym wzorcem bólu głowy skuteczność leczenia erenumabem jest niższa (56% odpowiedzi) w porównaniu do pacjentów bez codziennych bólów (90%). Czynniki takie jak depresja, zaburzenia lękowe, problemy ze snem, stres oraz niska samowystarczalność w zarządzaniu bólem (HMSE) są umiarkowanie powiązane z gorszym rokowaniem i odpowiedzią na leczenie profilaktyczne. Interwencje zwiększające samowystarczalność, jak w badaniu CHESS, wykazały minimalny, ale pozytywny wpływ na wyniki leczenia (średnia różnica 0,17 w skali HIT-6 po 12 miesiącach).

Prognoza chronicznych codziennych bólów głowy

Chroniczne codzienne bóle głowy (CDH) stanowią istotny problem medyczny, dotykający około 2-4% dorosłych w USA, z czego ponad 30% pacjentów zgłasza codzienne objawy. 1 Rokowanie w przypadku chronicznych bólów głowy jest złożone i zależy od wielu czynników. Każdego roku około 3-4% pacjentów z epizodycznymi migrenovymi lub napięciowymi bólami głowy doświadcza progresji do form przewlekłych. 2 Prognoza długoterminowa jest zróżnicowana i wymaga uwzględnienia wielu czynników prognostycznych.

Czynniki prognostyczne chronicznych codziennych bólów głowy

Badania naukowe zidentyfikowały szereg czynników prognostycznych związanych z przewlekłymi bólami głowy. Istnieją dowody o umiarkowanej jakości wskazujące, że depresja, zaburzenia lękowe, problemy ze snem, stres, nadużywanie leków przeciwbólowych oraz niska samowystarczalność w zarządzaniu bólami głowy (ang. headache management self-efficacy, HMSE) są potencjalnymi czynnikami prognostycznymi złego rokowania i niekorzystnych wyników leczenia profilaktycznego. 34

Najsilniejszymi czynnikami predykcyjnymi progresji bólów głowy są:5

Ciekawym odkryciem jest silny negatywny związek między występowaniem codziennego wzorca bólu głowy a odpowiedzią na leczenie niektórymi nowymi terapiami, jak erenumab. Badania wykazały, że wskaźnik pozytywnej odpowiedzi w grupie z codziennym bólem głowy wynosił 56% w porównaniu do 90% w grupie bez codziennego bólu głowy. 6

Przewidywanie wyników leczenia

Wyniki badań wskazują, że skuteczność interwencji terapeutycznych może być zależna od modyfikacji czynników prognostycznych. Na przykład, w analizie badania CHESS (Chronic Headache Education and Self-management Study) wykazano, że zmiana poziomu samowystarczalności w radzeniu sobie z bólem (PSEQ – Pain Self-Efficacy Questionnaire) pośredniczyła we wszystkich badanych wynikach leczenia, choć minimalnie. 7

Interwencja CHESS miała pozytywny wpływ na samowystarczalność po czterech miesiącach. Ta zmiana pośredniczyła w poprawie wyników w skali HIT-6 (Headache Impact Test) po 12 miesiącach, ale efekt był bardzo minimalny. Standardowa średnia różnica wynosiła zaledwie 0,17, co sugeruje, że potrzebne byłyby znacznie bardziej intensywne i/lub dłuższe interwencje, aby osiągnąć klinicznie istotny efekt. 89

Przebieg naturalny i czas trwania

Naturalny przebieg chronicznych codziennych bólów głowy różni się w zależności od podtypu. W przypadku nowego codziennego uporczywego bólu głowy (NDPH – New Daily Persistent Headache), który jest jednym z podtypów CDH, rokowanie jest zróżnicowane:10

  • U części pacjentów ból głowy utrzymuje się przez kilka lat, a następnie ustępuje (zwykle w ciągu trzech lat)
  • U innych pacjentów ból głowy nigdy nie ustępuje całkowicie
  • NDPH może być tak uciążliwy, że zaburza zdolność do pracy, uczestnictwa w aktywnościach społecznych i innych aspektach życia

W przypadku bólów głowy z nadużywania leków (MOH – Medication Overuse Headache), które występują u około 30-50% pacjentów rozwijających chroniczne bóle głowy, około 75% pacjentów doświadcza powrotu do epizodycznych migren lub napięciowych bólów głowy po odstawieniu nadużywanego leku. Jednak wskaźnik nawrotów wynosi około 30% rocznie, co wskazuje na potrzebę długoterminowego monitorowania i modyfikacji planu leczenia. 11

Konsekwencje psychologiczne i funkcjonalne

Chroniczny ból, w tym chroniczne codzienne bóle głowy, ma znaczący wpływ na dobrostan psychiczny pacjentów. Osoby cierpiące na chroniczny ból często rozwijają lub mają równoczesne zaburzenia zdrowia psychicznego, takie jak lęk i depresja. 12

Negatywny wpływ chronicznych bólów głowy na funkcjonowanie psychospołeczne obejmuje:

  • Rozwój zaburzeń lękowych i depresji związanych z przewlekłym bólem
  • Trudności diagnostyczne – pacjenci często muszą konsultować się z wieloma specjalistami przed uzyskaniem diagnozy
  • Wpływ na funkcjonowanie zawodowe i społeczne
  • Konieczność wielospecjalistycznej opieki, w tym wsparcia zdrowia psychicznego

13

Implikacje dla praktyki klinicznej

Identyfikacja potencjalnych czynników prognostycznych ma istotne znaczenie dla praktyki klinicznej:1415

  • Większość zidentyfikowanych czynników prognostycznych jest modyfikowalna, co stwarza możliwości interwencji terapeutycznych
  • Kluczowe znaczenie ma regularne monitorowanie wzorca bólu głowy i dostosowywanie planu leczenia
  • Przyszłe interwencje behawioralne powinny skupić się na maksymalizacji wpływu na samowystarczalność pacjenta w radzeniu sobie z bólem
  • Należy rozważyć, jakie inne czynniki mogłyby być celem interwencji w celu poprawy wyników leczenia

16

Potrzeby badawcze

Dostępne badania podkreślają potrzebę prowadzenia długoterminowych, wysokiej jakości badań nad czynnikami prognostycznymi w chronicznych bólach głowy. Przyszłe badania powinny być prowadzone jako duże, prospektywne, zarejestrowane i oparte na protokołach badania z wystarczającą populacją badaną i przejrzystym raportowaniem. 17

Badania sugerują również potrzebę opracowania bardziej intensywnych i/lub dłuższych interwencji terapeutycznych, aby osiągnąć klinicznie istotny efekt w leczeniu chronicznych bólów głowy. 18

Wnioski

Chroniczne codzienne bóle głowy stanowią trudny problem terapeutyczny z różnorodnym rokowaniem. Identyfikacja czynników prognostycznych, takich jak depresja, zaburzenia lękowe, problemy ze snem, stres, nadużywanie leków przeciwbólowych i niska samowystarczalność w zarządzaniu bólami głowy, ma kluczowe znaczenie dla optymalizacji leczenia. Większość tych czynników jest modyfikowalna, co daje możliwości skutecznej interwencji.

Przebieg naturalny zależy od podtypu bólu głowy, z różnym czasem trwania i odpowiedzią na leczenie. Regularne monitorowanie i dostosowywanie planu leczenia są niezbędne do optymalnego zarządzania tymi zaburzeniami. Przyszłe badania powinny skupić się na opracowaniu skuteczniejszych strategii leczenia ukierunkowanych na modyfikowalne czynniki prognostyczne oraz na poprawie długoterminowych wyników dla pacjentów z chronicznymi codziennymi bólami głowy. 1920

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Frequent Headaches: Evaluation and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/0401/p419.html
    An estimated 2% to 4% of U.S. adults have chronic headaches, and more than 30% of these report daily symptoms.68 Once central sensitization occurs, headaches are difficult to treat and cause substantial morbidity. […] Each year, 3% to 4% of patients with episodic migraine or tension-type headaches (TTH) escalate to chronic forms.5,6 […] The strongest predictive factors for headache progression are frequent headache episodes at baseline and medication overuse11. […] Chronic pain, especially musculoskeletal pain, and obesity are strongly associated with chronification. […] It is unclear if these are risk factors or comorbidities, or if they share etiologies with chronic headaches. […] Patients who develop chronic migraine typically report progressively frequent bilateral frontotemporal TTH-type symptoms with superimposed full-blown migraine attacks.
  • #2 Frequent Headaches: Evaluation and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/0401/p419.html
    An estimated 2% to 4% of U.S. adults have chronic headaches, and more than 30% of these report daily symptoms.68 Once central sensitization occurs, headaches are difficult to treat and cause substantial morbidity. […] Each year, 3% to 4% of patients with episodic migraine or tension-type headaches (TTH) escalate to chronic forms.5,6 […] The strongest predictive factors for headache progression are frequent headache episodes at baseline and medication overuse11. […] Chronic pain, especially musculoskeletal pain, and obesity are strongly associated with chronification. […] It is unclear if these are risk factors or comorbidities, or if they share etiologies with chronic headaches. […] Patients who develop chronic migraine typically report progressively frequent bilateral frontotemporal TTH-type symptoms with superimposed full-blown migraine attacks.
  • #3 Prognostic factors for chronic headache
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5513814/
    To identify predictors of prognosis and trial outcomes in prospective studies of people with chronic headache. […] There was moderate-quality evidence indicating that depression, anxiety, poor sleep and stress, medication overuse, and poor self-efficacy for managing headaches are potential prognostic factors for poor prognosis and unfavorable outcomes from preventive treatment in chronic headache. […] This review identified several potential predictors of poor prognosis and worse outcome postinterventions in people with chronic headache. The majority of these are modifiable. […] Our findings suggest with moderate-quality evidence that depression/anxiety, medication overuse, poor sleep, high stress, and low HMSE are associated with worse outcomes. […] The implication is that future research on prognostic factors in chronic headache should be ideally conducted as large, prospective, registered, and protocol-based studies with sufficient study populations and transparent reporting.
  • #4 Prognostic factors for chronic headache: A systematic review – PubMed
    https://pubmed.ncbi.nlm.nih.gov/28615422/
    Objective: To identify predictors of prognosis and trial outcomes in prospective studies of people with chronic headache. […] There was moderate-quality evidence indicating that depression, anxiety, poor sleep and stress, medication overuse, and poor self-efficacy for managing headaches are potential prognostic factors for poor prognosis and unfavorable outcomes from preventive treatment in chronic headache. […] This review identified several potential predictors of poor prognosis and worse outcome postinterventions in people with chronic headache. The majority of these are modifiable. The findings also highlight the need for more longitudinal high-quality research of prognostic factors in chronic headache.
  • #5 Frequent Headaches: Evaluation and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/0401/p419.html
    An estimated 2% to 4% of U.S. adults have chronic headaches, and more than 30% of these report daily symptoms.68 Once central sensitization occurs, headaches are difficult to treat and cause substantial morbidity. […] Each year, 3% to 4% of patients with episodic migraine or tension-type headaches (TTH) escalate to chronic forms.5,6 […] The strongest predictive factors for headache progression are frequent headache episodes at baseline and medication overuse11. […] Chronic pain, especially musculoskeletal pain, and obesity are strongly associated with chronification. […] It is unclear if these are risk factors or comorbidities, or if they share etiologies with chronic headaches. […] Patients who develop chronic migraine typically report progressively frequent bilateral frontotemporal TTH-type symptoms with superimposed full-blown migraine attacks.
  • #6 Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine: a clinical service evaluation | The Journal of Headache and Pain | Full Text
    https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-022-01456-2
    Erenumab was an effective treatment for chronic migraine in this treatment resistant population over 3 months of follow up. […] Presence of daily headache predicted poorer response but there was still a significant positive response rate in this group. […] Non-responders had a greater number of headache days at baseline. Specifically, the presence of daily headache at baseline was found to be associated with a lower rate of positive response to erenumab. Rate of positive response in the daily headache group was 56% compared to 90% in the non-daily headache group. […] Our evaluation for baseline characteristics that might predict response to erenumab revealed a striking novel negative association between the presence of a daily headache pattern and response to erenumab, with a 56% response rate in this group compared to 90% in the non-daily headache group.
  • #7 Does pain self-efficacy predict, moderate or mediate outcomes in people with chronic headache; an exploratory analysis of the CHESS trial | The Journal of Headache and Pain | Full Text
    https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01768-5
    PSEQ was not an effective predictor of outcome. However, change of short-term PSEQ mediated all outcomes, albeit minimally. Future behavioural therapy for chronic headache may need to consider how to achieve larger, and more sustained increases level of self-efficacy than that achieved within the CHESS trial. […] The CHESS intervention improved the mediated variable, PSEQ, by 2.34 (95% CI, 0.484 to 4.187) units and this corresponds to an increase of 0.21 (95% CI, 0.03 to 0.45) units in HIT-6 at 12-months. […] The total effect of treatment on change of HIT-6 from baseline to 12-month was 0.032 (p=0.95, result not shown), indicating that there was no treatment effect on HIT-6. […] Our observed standardised mean difference of 0.17 is even smaller indicating that a much more intense and/or lengthier intervention would be needed to have a clinically worthwhile effect.
  • #8 Does pain self-efficacy predict, moderate or mediate outcomes in people with chronic headache; an exploratory analysis of the CHESS trial | The Journal of Headache and Pain | Full Text
    https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01768-5
    PSEQ was not an effective predictor of outcome. However, change of short-term PSEQ mediated all outcomes, albeit minimally. Future behavioural therapy for chronic headache may need to consider how to achieve larger, and more sustained increases level of self-efficacy than that achieved within the CHESS trial. […] The CHESS intervention improved the mediated variable, PSEQ, by 2.34 (95% CI, 0.484 to 4.187) units and this corresponds to an increase of 0.21 (95% CI, 0.03 to 0.45) units in HIT-6 at 12-months. […] The total effect of treatment on change of HIT-6 from baseline to 12-month was 0.032 (p=0.95, result not shown), indicating that there was no treatment effect on HIT-6. […] Our observed standardised mean difference of 0.17 is even smaller indicating that a much more intense and/or lengthier intervention would be needed to have a clinically worthwhile effect.
  • #9 Does pain self-efficacy predict, moderate or mediate outcomes in people with chronic headache; an exploratory analysis of the CHESS trial | The Journal of Headache and Pain | Full Text
    https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01768-5
    The CHESS intervention has positive effect on self-efficacy at four months. This change in self-efficacy mediates an improvement in HIT-6 scores at 12 months, but is very minimal. Future behavioural interventions for people with chronic migraine need to consider how to maximise the effect on self-efficacy and to consider which other factors could be targeted.
  • #10 New Daily Persistent Headache (NDPH): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/24098-new-daily-persistent-headache-ndph
    If you have NDPH, you should expect a headache with moderate to severe pain. This headache lasts for at least three months, and the pain occurs every day and doesn’t stop. Some people do get relief from treatment, but many don’t. […] For some people, NDPH is something they’ll experience for years before it eventually goes away. The headache usually stops within three years for people who fall into this category. In others, the headache never goes away. When people have NDPH that doesn’t respond to treatment and doesn’t stop on its own, this condition can be so disruptive that it interferes with their ability to work, participate in social activities and more. Learning to live with this condition also can involve providers from multiple specialties, such as a mental health provider to treat the psychological effects of living with chronic pain.
  • #11 Frequent Headaches: Evaluation and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/0401/p419.html
    Patients developing chronic TTH or medication overuse headaches (MOH) often have nonspecific headaches. […] About 30% to 50% of patients who develop chronic headaches have MOH, which is defined as headache on 15 or more days per month in a patient with preexisting primary headache, developing as a consequence of regular overuse of acute or symptomatic headache medication for more than three months. […] In about 75% of patients with MOH, discontinuing the overused medication results in reversion to episodic migraine or TTH; however, the relapse rate is about 30% per year. […] Regularly scheduled follow-up is necessary to monitor the patient’s headache pattern and make adjustments to the management plan.
  • #12 New Daily Persistent Headache (NDPH): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/24098-new-daily-persistent-headache-ndph
    On its own, NDPH isn’t a dangerous condition. However, living with moderate or severe chronic pain is known to affect a person’s mental and emotional well-being negatively. People with chronic pain conditions commonly also develop or have mental health conditions like anxiety and depression. […] Because of all the above factors, people with NDPH may need to see multiple healthcare providers before they get a diagnosis. As this is a condition that providers can only truly diagnose after a person has symptoms for at least three months (though they can diagnose it as a probable case before that), people with NDPH often live with the symptoms without a definite answer on what’s causing their condition. That can further contribute to mental health concerns like anxiety and depression.
  • #13 New Daily Persistent Headache (NDPH): Symptoms & Treatment
    https://my.clevelandclinic.org/health/diseases/24098-new-daily-persistent-headache-ndph
    On its own, NDPH isn’t a dangerous condition. However, living with moderate or severe chronic pain is known to affect a person’s mental and emotional well-being negatively. People with chronic pain conditions commonly also develop or have mental health conditions like anxiety and depression. […] Because of all the above factors, people with NDPH may need to see multiple healthcare providers before they get a diagnosis. As this is a condition that providers can only truly diagnose after a person has symptoms for at least three months (though they can diagnose it as a probable case before that), people with NDPH often live with the symptoms without a definite answer on what’s causing their condition. That can further contribute to mental health concerns like anxiety and depression.
  • #14 Prognostic factors for chronic headache
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5513814/
    To identify predictors of prognosis and trial outcomes in prospective studies of people with chronic headache. […] There was moderate-quality evidence indicating that depression, anxiety, poor sleep and stress, medication overuse, and poor self-efficacy for managing headaches are potential prognostic factors for poor prognosis and unfavorable outcomes from preventive treatment in chronic headache. […] This review identified several potential predictors of poor prognosis and worse outcome postinterventions in people with chronic headache. The majority of these are modifiable. […] Our findings suggest with moderate-quality evidence that depression/anxiety, medication overuse, poor sleep, high stress, and low HMSE are associated with worse outcomes. […] The implication is that future research on prognostic factors in chronic headache should be ideally conducted as large, prospective, registered, and protocol-based studies with sufficient study populations and transparent reporting.
  • #15 Prognostic factors for chronic headache: A systematic review – PubMed
    https://pubmed.ncbi.nlm.nih.gov/28615422/
    Objective: To identify predictors of prognosis and trial outcomes in prospective studies of people with chronic headache. […] There was moderate-quality evidence indicating that depression, anxiety, poor sleep and stress, medication overuse, and poor self-efficacy for managing headaches are potential prognostic factors for poor prognosis and unfavorable outcomes from preventive treatment in chronic headache. […] This review identified several potential predictors of poor prognosis and worse outcome postinterventions in people with chronic headache. The majority of these are modifiable. The findings also highlight the need for more longitudinal high-quality research of prognostic factors in chronic headache.
  • #16 Does pain self-efficacy predict, moderate or mediate outcomes in people with chronic headache; an exploratory analysis of the CHESS trial | The Journal of Headache and Pain | Full Text
    https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01768-5
    The CHESS intervention has positive effect on self-efficacy at four months. This change in self-efficacy mediates an improvement in HIT-6 scores at 12 months, but is very minimal. Future behavioural interventions for people with chronic migraine need to consider how to maximise the effect on self-efficacy and to consider which other factors could be targeted.
  • #17 Prognostic factors for chronic headache
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5513814/
    To identify predictors of prognosis and trial outcomes in prospective studies of people with chronic headache. […] There was moderate-quality evidence indicating that depression, anxiety, poor sleep and stress, medication overuse, and poor self-efficacy for managing headaches are potential prognostic factors for poor prognosis and unfavorable outcomes from preventive treatment in chronic headache. […] This review identified several potential predictors of poor prognosis and worse outcome postinterventions in people with chronic headache. The majority of these are modifiable. […] Our findings suggest with moderate-quality evidence that depression/anxiety, medication overuse, poor sleep, high stress, and low HMSE are associated with worse outcomes. […] The implication is that future research on prognostic factors in chronic headache should be ideally conducted as large, prospective, registered, and protocol-based studies with sufficient study populations and transparent reporting.
  • #18 Does pain self-efficacy predict, moderate or mediate outcomes in people with chronic headache; an exploratory analysis of the CHESS trial | The Journal of Headache and Pain | Full Text
    https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-024-01768-5
    PSEQ was not an effective predictor of outcome. However, change of short-term PSEQ mediated all outcomes, albeit minimally. Future behavioural therapy for chronic headache may need to consider how to achieve larger, and more sustained increases level of self-efficacy than that achieved within the CHESS trial. […] The CHESS intervention improved the mediated variable, PSEQ, by 2.34 (95% CI, 0.484 to 4.187) units and this corresponds to an increase of 0.21 (95% CI, 0.03 to 0.45) units in HIT-6 at 12-months. […] The total effect of treatment on change of HIT-6 from baseline to 12-month was 0.032 (p=0.95, result not shown), indicating that there was no treatment effect on HIT-6. […] Our observed standardised mean difference of 0.17 is even smaller indicating that a much more intense and/or lengthier intervention would be needed to have a clinically worthwhile effect.
  • #19 Prognostic factors for chronic headache
    https://pmc.ncbi.nlm.nih.gov/articles/PMC5513814/
    To identify predictors of prognosis and trial outcomes in prospective studies of people with chronic headache. […] There was moderate-quality evidence indicating that depression, anxiety, poor sleep and stress, medication overuse, and poor self-efficacy for managing headaches are potential prognostic factors for poor prognosis and unfavorable outcomes from preventive treatment in chronic headache. […] This review identified several potential predictors of poor prognosis and worse outcome postinterventions in people with chronic headache. The majority of these are modifiable. […] Our findings suggest with moderate-quality evidence that depression/anxiety, medication overuse, poor sleep, high stress, and low HMSE are associated with worse outcomes. […] The implication is that future research on prognostic factors in chronic headache should be ideally conducted as large, prospective, registered, and protocol-based studies with sufficient study populations and transparent reporting.
  • #20 Prognostic factors for chronic headache: A systematic review – PubMed
    https://pubmed.ncbi.nlm.nih.gov/28615422/
    Objective: To identify predictors of prognosis and trial outcomes in prospective studies of people with chronic headache. […] There was moderate-quality evidence indicating that depression, anxiety, poor sleep and stress, medication overuse, and poor self-efficacy for managing headaches are potential prognostic factors for poor prognosis and unfavorable outcomes from preventive treatment in chronic headache. […] This review identified several potential predictors of poor prognosis and worse outcome postinterventions in people with chronic headache. The majority of these are modifiable. The findings also highlight the need for more longitudinal high-quality research of prognostic factors in chronic headache.